Global Cancer Genome Analysis Market Growth (Status and Outlook) 2021-2026

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cancer Genome Analysis Market Size 2016-2026

2.1.2 Cancer Genome Analysis Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Cancer Genome Analysis Segment by Type

2.2.1 Solid Tissue Analysis

2.2.2 Solid Tissue Analysis

2.3 Cancer Genome Analysis Market Size by Type

2.3.1 Global Cancer Genome Analysis Market Size CAGR by Type

2.3.2 Global Cancer Genome Analysis Market Size Market Share by Type (2016-2021)

2.4 Cancer Genome Analysis Segment by Application

2.4.1 Clinical

2.4.2 Pharmaceutical

2.4.3 Research

2.5 Cancer Genome Analysis Market Size by Application

2.5.1 Global Cancer Genome Analysis Market Size CAGR by Application

2.5.2 Global Cancer Genome Analysis Market Size Market Share by Application (2016-2021)

3 Cancer Genome Analysis Market Size by Players

3.1 Cancer Genome Analysis Market Size Market Share by Players

3.1.1 Global Cancer Genome Analysis Revenue by Players (2019-2021E)

3.1.2 Global Cancer Genome Analysis Revenue Market Share by Players (2019-2021E)

3.2 Global Cancer Genome Analysis Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Cancer Genome Analysis by Regions

4.1 Cancer Genome Analysis Market Size by Regions (2016-2021)

4.2 Americas Cancer Genome Analysis Market Size Growth (2016-2021)

4.3 APAC Cancer Genome Analysis Market Size Growth (2016-2021)

4.4 Europe Cancer Genome Analysis Market Size Growth (2016-2021)

4.5 Middle East & Africa Cancer Genome Analysis Market Size Growth (2016-2021)

5 Americas

5.1 Americas Cancer Genome Analysis Market Size by Country (2016-2021)

5.2 Americas Cancer Genome Analysis Market Size by Type (2016-2021)

5.3 Americas Cancer Genome Analysis Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cancer Genome Analysis Market Size by Region (2016-2021)

6.2 APAC Cancer Genome Analysis Market Size by Type (2016-2021)

6.3 APAC Cancer Genome Analysis Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Cancer Genome Analysis by Country (2016-2021)

7.2 Europe Cancer Genome Analysis Market Size by Type (2016-2021)

7.3 Europe Cancer Genome Analysis Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cancer Genome Analysis by Region (2016-2021)

8.2 Middle East & Africa Cancer Genome Analysis Market Size by Type (2016-2021)

8.3 Middle East & Africa Cancer Genome Analysis Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Cancer Genome Analysis Market Forecast

10.1 Global Cancer Genome Analysis Forecast by Regions (2021-2026)

10.1.1 Global Cancer Genome Analysis Forecast by Regions (2021-2026)

10.1.2 Americas Cancer Genome Analysis Forecast

10.1.3 APAC Cancer Genome Analysis Forecast

10.1.4 Europe Cancer Genome Analysis Forecast

10.1.5 Middle East & Africa Cancer Genome Analysis Forecast

10.2 Americas Cancer Genome Analysis Forecast by Countries (2021-2026)

10.2.1 United States Cancer Genome Analysis Market Forecast

10.2.2 Canada Cancer Genome Analysis Market Forecast

10.2.3 Mexico Cancer Genome Analysis Market Forecast

10.2.4 Brazil Cancer Genome Analysis Market Forecast

10.3 APAC Cancer Genome Analysis Forecast by Region (2021-2026)

10.3.1 China Cancer Genome Analysis Market Forecast

10.3.2 Japan Cancer Genome Analysis Market Forecast

10.3.3 Korea Cancer Genome Analysis Market Forecast

10.3.4 Southeast Asia Cancer Genome Analysis Market Forecast

10.3.5 India Cancer Genome Analysis Market Forecast

10.3.6 Australia Cancer Genome Analysis Market Forecast

10.4 Europe Cancer Genome Analysis Forecast by Country (2021-2026)

10.4.1 Germany Cancer Genome Analysis Market Forecast

10.4.2 France Cancer Genome Analysis Market Forecast

10.4.3 UK Cancer Genome Analysis Market Forecast

10.4.4 Italy Cancer Genome Analysis Market Forecast

10.4.5 Russia Cancer Genome Analysis Market Forecast

10.5 Middle East & Africa Cancer Genome Analysis Forecast by Region (2021-2026)

10.5.1 Egypt Cancer Genome Analysis Market Forecast

10.5.2 South Africa Cancer Genome Analysis Market Forecast

10.5.3 Israel Cancer Genome Analysis Market Forecast

10.5.4 Turkey Cancer Genome Analysis Market Forecast

10.5.5 GCC Countries Cancer Genome Analysis Market Forecast

10.6 Global Cancer Genome Analysis Forecast by Type (2021-2026)

10.7 Global Cancer Genome Analysis Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 Abbott Diagnostics

11.1.1 Abbott Diagnostics Company Information

11.1.2 Abbott Diagnostics Cancer Genome Analysis Product Offered

11.1.3 Abbott Diagnostics Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 Abbott Diagnostics Main Business Overview

11.1.5 Abbott Diagnostics Latest Developments

11.2 AccuraGen Inc

11.2.1 AccuraGen Inc Company Information

11.2.2 AccuraGen Inc Cancer Genome Analysis Product Offered

11.2.3 AccuraGen Inc Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 AccuraGen Inc Main Business Overview

11.2.5 AccuraGen Inc Latest Developments

11.3 Acuamark Diagnostics

11.3.1 Acuamark Diagnostics Company Information

11.3.2 Acuamark Diagnostics Cancer Genome Analysis Product Offered

11.3.3 Acuamark Diagnostics Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Acuamark Diagnostics Main Business Overview

11.3.5 Acuamark Diagnostics Latest Developments

11.4 Admera Health, LLC

11.4.1 Admera Health, LLC Company Information

11.4.2 Admera Health, LLC Cancer Genome Analysis Product Offered

11.4.3 Admera Health, LLC Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 Admera Health, LLC Main Business Overview

11.4.5 Admera Health, LLC Latest Developments

11.5 Agena Bioscience, Inc

11.5.1 Agena Bioscience, Inc Company Information

11.5.2 Agena Bioscience, Inc Cancer Genome Analysis Product Offered

11.5.3 Agena Bioscience, Inc Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 Agena Bioscience, Inc Main Business Overview

11.5.5 Agena Bioscience, Inc Latest Developments

11.6 Agilent

11.6.1 Agilent Company Information

11.6.2 Agilent Cancer Genome Analysis Product Offered

11.6.3 Agilent Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 Agilent Main Business Overview

11.6.5 Agilent Latest Developments

11.7 Almac Diagnostics

11.7.1 Almac Diagnostics Company Information

11.7.2 Almac Diagnostics Cancer Genome Analysis Product Offered

11.7.3 Almac Diagnostics Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 Almac Diagnostics Main Business Overview

11.7.5 Almac Diagnostics Latest Developments

11.8 Amoy Diagnostics Co., Ltd.

11.8.1 Amoy Diagnostics Co., Ltd. Company Information

11.8.2 Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Product Offered

11.8.3 Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 Amoy Diagnostics Co., Ltd. Main Business Overview

11.8.5 Amoy Diagnostics Co., Ltd. Latest Developments

11.9 Anchor Dx

11.9.1 Anchor Dx Company Information

11.9.2 Anchor Dx Cancer Genome Analysis Product Offered

11.9.3 Anchor Dx Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 Anchor Dx Main Business Overview

11.9.5 Anchor Dx Latest Developments

11.10 ANGLE plc

11.10.1 ANGLE plc Company Information

11.10.2 ANGLE plc Cancer Genome Analysis Product Offered

11.10.3 ANGLE plc Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.10.4 ANGLE plc Main Business Overview

11.10.5 ANGLE plc Latest Developments

11. ApoCell, Inc.

11.11.1 ApoCell, Inc. Company Information

11.11.2 ApoCell, Inc. Cancer Genome Analysis Product Offered

11.11.3 ApoCell, Inc. Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.11.4 ApoCell, Inc. Main Business Overview

11.11.5 ApoCell, Inc. Latest Developments

11.12 ArcherDx, Inc

11.12.1 ArcherDx, Inc Company Information

11.12.2 ArcherDx, Inc Cancer Genome Analysis Product Offered

11.12.3 ArcherDx, Inc Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.12.4 ArcherDx, Inc Main Business Overview

11.12.5 ArcherDx, Inc Latest Developments

11.13 Asuragen

11.13.1 Asuragen Company Information

11.13.2 Asuragen Cancer Genome Analysis Product Offered

11.13.3 Asuragen Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.13.4 Asuragen Main Business Overview

11.13.5 Asuragen Latest Developments

11.14 AVIVA Biosciences

11.14.1 AVIVA Biosciences Company Information

11.14.2 AVIVA Biosciences Cancer Genome Analysis Product Offered

11.14.3 AVIVA Biosciences Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.14.4 AVIVA Biosciences Main Business Overview

11.14.5 AVIVA Biosciences Latest Developments

11.15 Baylor Miraca Genetics Laboratories

11.15.1 Baylor Miraca Genetics Laboratories Company Information

11.15.2 Baylor Miraca Genetics Laboratories Cancer Genome Analysis Product Offered

11.15.3 Baylor Miraca Genetics Laboratories Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.15.4 Baylor Miraca Genetics Laboratories Main Business Overview

11.15.5 Baylor Miraca Genetics Laboratories Latest Developments

11.16 Beckman Coulter, Inc.

11.16.1 Beckman Coulter, Inc. Company Information

11.16.2 Beckman Coulter, Inc. Cancer Genome Analysis Product Offered

11.16.3 Beckman Coulter, Inc. Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.16.4 Beckman Coulter, Inc. Main Business Overview

11.16.5 Beckman Coulter, Inc. Latest Developments

11.17 Becton, Dickinson and Company

11.17.1 Becton, Dickinson and Company Company Information

11.17.2 Becton, Dickinson and Company Cancer Genome Analysis Product Offered

11.17.3 Becton, Dickinson and Company Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.17.4 Becton, Dickinson and Company Main Business Overview

11.17.5 Becton, Dickinson and Company Latest Developments

11.18 BGI Genomics Co. Ltd

11.18.1 BGI Genomics Co. Ltd Company Information

11.18.2 BGI Genomics Co. Ltd Cancer Genome Analysis Product Offered

11.18.3 BGI Genomics Co. Ltd Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.18.4 BGI Genomics Co. Ltd Main Business Overview

11.18.5 BGI Genomics Co. Ltd Latest Developments

11.19 Bioarray Genetics

11.19.1 Bioarray Genetics Company Information

11.19.2 Bioarray Genetics Cancer Genome Analysis Product Offered

11.19.3 Bioarray Genetics Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.19.4 Bioarray Genetics Main Business Overview

11.19.5 Bioarray Genetics Latest Developments

11.20 Biocartis

11.20.1 Biocartis Company Information

11.20.2 Biocartis Cancer Genome Analysis Product Offered

11.20.3 Biocartis Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.20.4 Biocartis Main Business Overview

11.20.5 Biocartis Latest Developments

11.21 Biocept, Inc

11.21.1 Biocept, Inc Company Information

11.21.2 Biocept, Inc Cancer Genome Analysis Product Offered

11.21.3 Biocept, Inc Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.21.4 Biocept, Inc Main Business Overview

11.21.5 Biocept, Inc Latest Developments

11.22 Biodesix Inc

11.22.1 Biodesix Inc Company Information

11.22.2 Biodesix Inc Cancer Genome Analysis Product Offered

11.22.3 Biodesix Inc Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.22.4 Biodesix Inc Main Business Overview

11.22.5 Biodesix Inc Latest Developments

11.23 BioFluidica

11.23.1 BioFluidica Company Information

11.23.2 BioFluidica Cancer Genome Analysis Product Offered

11.23.3 BioFluidica Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.23.4 BioFluidica Main Business Overview

11.23.5 BioFluidica Latest Developments

11.24 bioMérieux Diagnostics

11.24.1 bioMérieux Diagnostics Company Information

11.24.2 bioMérieux Diagnostics Cancer Genome Analysis Product Offered

11.24.3 bioMérieux Diagnostics Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.24.4 bioMérieux Diagnostics Main Business Overview

11.24.5 bioMérieux Diagnostics Latest Developments

11.25 Bioneer Corporation

11.25.1 Bioneer Corporation Company Information

11.25.2 Bioneer Corporation Cancer Genome Analysis Product Offered

11.25.3 Bioneer Corporation Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.25.4 Bioneer Corporation Main Business Overview

11.25.5 Bioneer Corporation Latest Developments

11.26 Bio-Rad Laboratories, Inc

11.26.1 Bio-Rad Laboratories, Inc Company Information

11.26.2 Bio-Rad Laboratories, Inc Cancer Genome Analysis Product Offered

11.26.3 Bio-Rad Laboratories, Inc Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.26.4 Bio-Rad Laboratories, Inc Main Business Overview

11.26.5 Bio-Rad Laboratories, Inc Latest Developments

11.27 Bio-Techne

11.27.1 Bio-Techne Company Information

11.27.2 Bio-Techne Cancer Genome Analysis Product Offered

11.27.3 Bio-Techne Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

11.27.4 Bio-Techne Main Business Overview

11.27.5 Bio-Techne Latest Developments

12 Research Findings and Conclusion

Table 1. Cancer Genome Analysis Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Solid Tissue Analysis

Table 3. Major Players of Liquid Tissue Analysis

Table 4. Cancer Genome Analysis Market Size CAGR by Type (2020-2026) & ($ Millions)

Table 5. Global Cancer Genome Analysis Market Size by Type (2016-2021) & ($ Millions)

Table 6. Global Cancer Genome Analysis Market Size Market Share by Type (2016-2021)

Table 7. Cancer Genome Analysis Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 8. Global Cancer Genome Analysis Market Size by Application (2016-2021) & ($ Millions)

Table 9. Global Cancer Genome Analysis Market Size Market Share by Application (2016-2021)

Table 10. Global Cancer Genome Analysis Revenue by Players (2019-2021E) & ($ Millions)

Table 11. Global Cancer Genome Analysis Revenue Market Share by Players (2019-2021E)

Table 12. Cancer Genome Analysis Key Players Head office and Products Offered

Table 13. Cancer Genome Analysis Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Cancer Genome Analysis Market Size by Regions 2016-2021 & ($ Millions)

Table 17. Global Cancer Genome Analysis Market Size Market Share by Regions 2016-2021

Table 18. Americas Cancer Genome Analysis Market Size by Country (2016-2021) & ($ Millions)

Table 19. Americas Cancer Genome Analysis Market Size Market Share by Country (2016-2021)

Table 20. Americas Cancer Genome Analysis Market Size by Type (2016-2021) & ($ Millions)

Table 21. Americas Cancer Genome Analysis Market Size Market Share by Type (2016-2021)

Table 22. Americas Cancer Genome Analysis Market Size by Application (2016-2021) & ($ Millions)

Table 23. Americas Cancer Genome Analysis Market Size Market Share by Application (2016-2021)

Table 24. APAC Cancer Genome Analysis Market Size by Region (2016-2021) & ($ Millions)

Table 25. APAC Cancer Genome Analysis Market Size Market Share by Region (2016-2021)

Table 26. APAC Cancer Genome Analysis Market Size by Type (2016-2021) & ($ Millions)

Table 27. APAC Cancer Genome Analysis Market Size Market Share by Type (2016-2021)

Table 28. APAC Cancer Genome Analysis Market Size by Application (2016-2021) & ($ Millions)

Table 29. APAC Cancer Genome Analysis Market Size Market Share by Application (2016-2021)

Table 30. Europe Cancer Genome Analysis Market Size by Country (2016-2021) & ($ Millions)

Table 31. Europe Cancer Genome Analysis Market Size Market Share by Country (2016-2021)

Table 32. Europe Cancer Genome Analysis Market Size by Type (2016-2021) & ($ Millions)

Table 33. Europe Cancer Genome Analysis Market Size Market Share by Type (2016-2021)

Table 34. Europe Cancer Genome Analysis Market Size by Application (2016-2021) & ($ Millions)

Table 35. Europe Cancer Genome Analysis Market Size Market Share by Application (2016-2021)

Table 36. Middle East & Africa Cancer Genome Analysis Market Size by Region (2016-2021) & ($ Millions)

Table 37. Middle East & Africa Cancer Genome Analysis Market Size Market Share by Region (2016-2021)

Table 38. Middle East & Africa Cancer Genome Analysis Market Size by Type (2016-2021) & ($ Millions)

Table 39. Middle East & Africa Cancer Genome Analysis Market Size Market Share by Type (2016-2021)

Table 40. Middle East & Africa Cancer Genome Analysis Market Size by Application (2016-2021) & ($ Millions)

Table 41. Middle East & Africa Cancer Genome Analysis Market Size Market Share by Application (2016-2021)

Table 42. Key and Potential Regions of Cancer Genome Analysis

Table 43. Key Application and Potential Industries of Cancer Genome Analysis

Table 44. Key Challenges of Cancer Genome Analysis

Table 45. Key Trends of Cancer Genome Analysis

Table 46. Global Cancer Genome Analysis Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 47. Global Cancer Genome Analysis Market Size Market Share Forecast by Regions (2021-2026)

Table 48. Global Cancer Genome Analysis Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 49. Global Cancer Genome Analysis Market Size Market Share Forecast by Type (2021-2026)

Table 50. Global Cancer Genome Analysis Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 51. Global Cancer Genome Analysis Market Size Market Share Forecast by Application (2021-2026)

Table 52. Abbott Diagnostics Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 53. Abbott Diagnostics Cancer Genome Analysis Product Offered

Table 54. Abbott Diagnostics Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 55. Abbott Diagnostics Main Business

Table 56. Abbott Diagnostics Latest Developments

Table 57. AccuraGen Inc Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 58. AccuraGen Inc Cancer Genome Analysis Product Offered

Table 59. AccuraGen Inc Main Business

Table 60. AccuraGen Inc Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 61. AccuraGen Inc Latest Developments

Table 62. Acuamark Diagnostics Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 63. Acuamark Diagnostics Cancer Genome Analysis Product Offered

Table 64. Acuamark Diagnostics Main Business

Table 65. Acuamark Diagnostics Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 66. Acuamark Diagnostics Latest Developments

Table 67. Admera Health, LLC Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 68. Admera Health, LLC Cancer Genome Analysis Product Offered

Table 69. Admera Health, LLC Main Business

Table 70. Admera Health, LLC Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 71. Admera Health, LLC Latest Developments

Table 72. Agena Bioscience, Inc Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 73. Agena Bioscience, Inc Cancer Genome Analysis Product Offered

Table 74. Agena Bioscience, Inc Main Business

Table 75. Agena Bioscience, Inc Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 76. Agena Bioscience, Inc Latest Developments

Table 77. Agilent Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 78. Agilent Cancer Genome Analysis Product Offered

Table 79. Agilent Main Business

Table 80. Agilent Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 81. Agilent Latest Developments

Table 82. Almac Diagnostics Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 83. Almac Diagnostics Cancer Genome Analysis Product Offered

Table 84. Almac Diagnostics Main Business

Table 85. Almac Diagnostics Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 86. Almac Diagnostics Latest Developments

Table 87. Amoy Diagnostics Co., Ltd. Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 88. Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Product Offered

Table 89. Amoy Diagnostics Co., Ltd. Main Business

Table 90. Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 91. Amoy Diagnostics Co., Ltd. Latest Developments

Table 92. Anchor Dx Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 93. Anchor Dx Cancer Genome Analysis Product Offered

Table 94. Anchor Dx Main Business

Table 95. Anchor Dx Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 96. Anchor Dx Latest Developments

Table 97. ANGLE plc Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 98. ANGLE plc Cancer Genome Analysis Product Offered

Table 99. ANGLE plc Main Business

Table 100. ANGLE plc Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 101. ANGLE plc Latest Developments

Table 102. ApoCell, Inc. Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 103. ApoCell, Inc. Cancer Genome Analysis Product Offered

Table 104. ApoCell, Inc. Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 105. ApoCell, Inc. Main Business

Table 106. ApoCell, Inc. Latest Developments

Table 107. ArcherDx, Inc Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 108. ArcherDx, Inc Cancer Genome Analysis Product Offered

Table 109. ArcherDx, Inc Main Business

Table 110. ArcherDx, Inc Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 111. ArcherDx, Inc Latest Developments

Table 112. Asuragen Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 113. Asuragen Cancer Genome Analysis Product Offered

Table 114. Asuragen Main Business

Table 115. Asuragen Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 116. Asuragen Latest Developments

Table 117. AVIVA Biosciences Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 118. AVIVA Biosciences Cancer Genome Analysis Product Offered

Table 119. AVIVA Biosciences Main Business

Table 120. AVIVA Biosciences Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 121. AVIVA Biosciences Latest Developments

Table 122. Baylor Miraca Genetics Laboratories Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 123. Baylor Miraca Genetics Laboratories Cancer Genome Analysis Product Offered

Table 124. Baylor Miraca Genetics Laboratories Main Business

Table 125. Baylor Miraca Genetics Laboratories Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 126. Baylor Miraca Genetics Laboratories Latest Developments

Table 127. Beckman Coulter, Inc. Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 128. Beckman Coulter, Inc. Cancer Genome Analysis Product Offered

Table 129. Beckman Coulter, Inc. Main Business

Table 130. Beckman Coulter, Inc. Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 131. Beckman Coulter, Inc. Latest Developments

Table 132. Becton, Dickinson and Company Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 133. Becton, Dickinson and Company Cancer Genome Analysis Product Offered

Table 134. Becton, Dickinson and Company Main Business

Table 135. Becton, Dickinson and Company Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 136. Becton, Dickinson and Company Latest Developments

Table 137. BGI Genomics Co. Ltd Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 138. BGI Genomics Co. Ltd Cancer Genome Analysis Product Offered

Table 139. BGI Genomics Co. Ltd Main Business

Table 140. BGI Genomics Co. Ltd Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 141. BGI Genomics Co. Ltd Latest Developments

Table 142. Bioarray Genetics Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 143. Bioarray Genetics Cancer Genome Analysis Product Offered

Table 144. Bioarray Genetics Main Business

Table 145. Bioarray Genetics Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 146. Bioarray Genetics Latest Developments

Table 147. Biocartis Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 148. Biocartis Cancer Genome Analysis Product Offered

Table 149. Biocartis Main Business

Table 150. Biocartis Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 151. Biocartis Latest Developments

Table 152. Biocept, Inc Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 153. Biocept, Inc Cancer Genome Analysis Product Offered

Table 154. Biocept, Inc Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 155. Biocept, Inc Main Business

Table 156. Biocept, Inc Latest Developments

Table 157. Biodesix Inc Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 158. Biodesix Inc Cancer Genome Analysis Product Offered

Table 159. Biodesix Inc Main Business

Table 160. Biodesix Inc Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 161. Biodesix Inc Latest Developments

Table 162. BioFluidica Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 163. BioFluidica Cancer Genome Analysis Product Offered

Table 164. BioFluidica Main Business

Table 165. BioFluidica Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 166. BioFluidica Latest Developments

Table 167. bioMérieux Diagnostics Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 168. bioMérieux Diagnostics Cancer Genome Analysis Product Offered

Table 169. bioMérieux Diagnostics Main Business

Table 170. bioMérieux Diagnostics Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 171. bioMérieux Diagnostics Latest Developments

Table 172. Bioneer Corporation Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 173. Bioneer Corporation Cancer Genome Analysis Product Offered

Table 174. Bioneer Corporation Main Business

Table 175. Bioneer Corporation Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 176. Bioneer Corporation Latest Developments

Table 177. Bio-Rad Laboratories, Inc Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 178. Bio-Rad Laboratories, Inc Cancer Genome Analysis Product Offered

Table 179. Bio-Rad Laboratories, Inc Main Business

Table 180. Bio-Rad Laboratories, Inc Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 181. Bio-Rad Laboratories, Inc Latest Developments

Table 182. Bio-Techne Details, Company Type, Cancer Genome Analysis Area Served and Its Competitors

Table 183. Bio-Techne Cancer Genome Analysis Product Offered

Table 184. Bio-Techne Main Business

Table 185. Bio-Techne Cancer Genome Analysis Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 186. Bio-Techne Latest Developments

List of Figures

Figure 1. Cancer Genome Analysis Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Cancer Genome Analysis Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Cancer Genome Analysis Market Size Market Share by Type in 2020

Figure 7. Cancer Genome Analysis in Clinical

Figure 8. Global Cancer Genome Analysis Market: Clinical (2016-2021) & ($ Millions)

Figure 9. Cancer Genome Analysis in Pharmaceutical

Figure 10. Global Cancer Genome Analysis Market: Pharmaceutical (2016-2021) & ($ Millions)

Figure 11. Cancer Genome Analysis in Research

Figure 12. Global Cancer Genome Analysis Market: Research (2016-2021) & ($ Millions)

Figure 13. Global Cancer Genome Analysis Market Size Market Share by Application in 2020

Figure 14. Global Cancer Genome Analysis Revenue Market Share by Player in 2020

Figure 15. Global Cancer Genome Analysis Market Size Market Share by Regions (2016-2021)

Figure 16. Americas Cancer Genome Analysis Market Size 2016-2021 ($ Millions)

Figure 17. APAC Cancer Genome Analysis Market Size 2016-2021 ($ Millions)

Figure 18. Europe Cancer Genome Analysis Market Size 2016-2021 ($ Millions)

Figure 19. Middle East & Africa Cancer Genome Analysis Market Size 2016-2021 ($ Millions)

Figure 20. Americas Cancer Genome Analysis Market Size Market Share by Country in 2020

Figure 21. Americas Cancer Genome Analysis Market Size Market Share by Type in 2020

Figure 22. Americas Cancer Genome Analysis Market Size Market Share by Application in 2020

Figure 23. United States Cancer Genome Analysis Market Size Growth 2016-2021 ($ Millions)

Figure 24. Canada Cancer Genome Analysis Market Size Growth 2016-2021 ($ Millions)

Figure 25. Mexico Cancer Genome Analysis Market Size Growth 2016-2021 ($ Millions)

Figure 26. APAC Cancer Genome Analysis Market Size Market Share by Regions in 2020

Figure 27. APAC Cancer Genome Analysis Market Size Market Share by Type in 2020

Figure 28. APAC Cancer Genome Analysis Market Size Market Share by Application in 2020

Figure 29. China Cancer Genome Analysis Market Size Growth 2016-2021 ($ Millions)

Figure 30. Japan Cancer Genome Analysis Market Size Growth 2016-2021 ($ Millions)

Figure 31. Korea Cancer Genome Analysis Market Size Growth 2016-2021 ($ Millions)

Figure 32. Southeast Asia Cancer Genome Analysis Market Size Growth 2016-2021 ($ Millions)

Figure 33. India Cancer Genome Analysis Market Size Growth 2016-2021 ($ Millions)

Figure 34. Australia Cancer Genome Analysis Market Size Growth 2016-2021 ($ Millions)

Figure 35. Europe Cancer Genome Analysis Market Size Market Share by Country in 2020

Figure 36. Europe Cancer Genome Analysis Market Size Market Share by Type in 2020

Figure 37. Europe Cancer Genome Analysis Market Size Market Share by Application in 2020

Figure 38. Germany Cancer Genome Analysis Market Size Growth 2016-2021 ($ Millions)

Figure 39. France Cancer Genome Analysis Market Size Growth 2016-2021 ($ Millions)

Figure 40. UK Cancer Genome Analysis Market Size Growth 2016-2021 ($ Millions)

Figure 41. Italy Cancer Genome Analysis Market Size Growth 2016-2021 ($ Millions)

Figure 42. Russia Cancer Genome Analysis Market Size Growth 2016-2021 ($ Millions)

Figure 43. Middle East & Africa Cancer Genome Analysis Market Size Market Share by Region in 2020

Figure 44. Middle East & Africa Cancer Genome Analysis Market Size Market Share by Type in 2020

Figure 45. Middle East & Africa Cancer Genome Analysis Market Size Market Share by Application in 2020

Figure 46. Egypt Cancer Genome Analysis Market Size Growth 2016-2021 ($ Millions)

Figure 47. South Africa Cancer Genome Analysis Market Size Growth 2016-2021 ($ Millions)

Figure 48. Israel Cancer Genome Analysis Market Size Growth 2016-2021 ($ Millions)

Figure 49. Turkey Cancer Genome Analysis Market Size Growth 2016-2021 ($ Millions)

Figure 50. GCC Country Cancer Genome Analysis Market Size Growth 2016-2021 ($ Millions)

Figure 51. Americas Cancer Genome Analysis Market Size 2021-2026 ($ Millions)

Figure 52. APAC Cancer Genome Analysis Market Size 2021-2026 ($ Millions)

Figure 53. Europe Cancer Genome Analysis Market Size 2021-2026 ($ Millions)

Figure 54. Middle East & Africa Cancer Genome Analysis Market Size 2021-2026 ($ Millions)

Figure 55. United States Cancer Genome Analysis Market Size 2021-2026 ($ Millions)

Figure 56. Canada Cancer Genome Analysis Market Size 2021-2026 ($ Millions)

Figure 57. Mexico Cancer Genome Analysis Market Size 2021-2026 ($ Millions)

Figure 58. Brazil Cancer Genome Analysis Market Size 2021-2026 ($ Millions)

Figure 59. China Cancer Genome Analysis Market Size 2021-2026 ($ Millions)

Figure 60. Japan Cancer Genome Analysis Market Size 2021-2026 ($ Millions)

Figure 61. Korea Cancer Genome Analysis Market Size 2021-2026 ($ Millions)

Figure 62. Southeast Asia Cancer Genome Analysis Market Size 2021-2026 ($ Millions)

Figure 63. India Cancer Genome Analysis Market Size 2021-2026 ($ Millions)

Figure 64. Australia Cancer Genome Analysis Market Size 2021-2026 ($ Millions)

Figure 65. Germany Cancer Genome Analysis Market Size 2021-2026 ($ Millions)

Figure 66. France Cancer Genome Analysis Market Size 2021-2026 ($ Millions)

Figure 67. UK Cancer Genome Analysis Market Size 2021-2026 ($ Millions)

Figure 68. Italy Cancer Genome Analysis Market Size 2021-2026 ($ Millions)

Figure 69. Russia Cancer Genome Analysis Market Size 2021-2026 ($ Millions)

Figure 70. Spain Cancer Genome Analysis Market Size 2021-2026 ($ Millions)

Figure 71. Egypt Cancer Genome Analysis Market Size 2021-2026 ($ Millions)

Figure 72. South Africa Cancer Genome Analysis Market Size 2021-2026 ($ Millions)

Figure 73. Israel Cancer Genome Analysis Market Size 2021-2026 ($ Millions)

Figure 74. Turkey Cancer Genome Analysis Market Size 2021-2026 ($ Millions)

Figure 75. GCC Country Cancer Genome Analysis Market Size 2021-2026 ($ Millions)